Key Morningstar Metrics for Curaleaf Holdings
What We Thought of Curaleaf Holdings’ Earnings
Curaleaf Holdings’ CURA fourth-quarter revenue grew 2% year over year to USD 333 million. International revenue contributed USD 51 million (a 65% increase) to offset domestic’s 5% decline (to USD 282 million). Price compression continued, with Curaleaf’s markets again suffering double-digit percentage declines.
Why it matters: Price compression continues to plague the industry, though Curaleaf’s product innovation has blunted the impact on its sales. We think there’s an eventual bottom, as falling prices will force small producers to close and supply will drop.
- A stubborn illicit market, an unregulated hemp-derived market, and…
